Mifepristone (RU 486) for Alzheimer's disease.
Pomara
Nunzio
N
Department of Psychiatry, New York University School of Medicine, USA. pomara@nki.rfmh.org
Doraiswamy
P Murali
PM
Tun
Hla
H
Ferris
Steven
S
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D000855:Anorexia / Q000209:etiology; D003071:Cognition / Q000187:drug effects; D004311:Double-Blind Method; D003875:Drug Eruptions / Q000209:etiology; D005221:Fatigue / Q000209:etiology; D005260:Female; D006261:Headache / Q000209:etiology; D006727:Hormone Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007008:Hypokalemia / Q000209:etiology; D008297:Male; D015735:Mifepristone / Q000009:adverse effects / Q000627:therapeutic use*; D009483:Neuropsychological Tests; D010865:Pilot Projects; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
D006727:Hormone Antagonists; D011965:Receptors, Glucocorticoid; D015735:Mifepristone